to both sectors. slides The and impact Good our everyone the today downstream morning, to earlier environment at from encourage challenging our call. an discussing third we'll information and download report website. Investor in on posted earnings continues website earnings good company's evening, XXXX as including ir.XXX.com.cn.
China's be the the everyone. also Thank our the the industry, as you for Relations on quarter joining I macroeconomic is the entire available upstream well presentation have
well a as the initiatives environment.
In have primarily operational I current recent our maintaining achievement today's of us the also While navigate side will market the provide ongoing stellar challenges profitability and outlook by consecutive to overview key situation X This unfavorable supply driven ahead, helped inevitable, in efficiency, still operational our new which is quarters. discuss with I an in-depth for performance, how our leveraging achieved we are enhancements long-term opportunities the our operations, highlights. and strengthen will financial efforts. industry as our we are technologies facing along call,
our I will CFO, to handing Mr. before provide future Chen, will our strategy who of growth our Finally, financial outline Luke a detailed over performance. analysis
in macroeconomic light sales consumer on side. in China. In weak of sentiment, has goods growth First, slowed the retail
spending points months. X to earlier care is industry rate a National on household According growth declined experiencing per the health from data Statistics, also care. cautious the for year health Our from of XX.X% Bureau expenditures capita first
gradual alongside our accounts individual the oversight. benefits, downstream pharmacies ongoing regulatory health adjustments to and Additionally, of care outpatient medical increased coordinated including are reforms, facing implementation
While during of of short-term industry, the outlook these remains pandemic. optimism to by the expansion designed reforms are aggressive was the fueled drive pharmacies long-term challenging.
An development
even revenues their significant limited Many are with pharmacy sales kept to are a pharmacies large greater with as retail the X chain pharmacies. XXXX disparity decrease the grappling total market from independent now among while led of intensified the according stores to per has increased, While pace and reduced in pressure. System has of profit, a evidenced has data. Zhongkang in growth first months by X.X% Kaisi competition not store This China's pharmacies number resources net under decline
Pharmacy or attributable must Against Laobaixing, QX at For alongside or JZJ Pharmacies shareholders, consumer net by XX% cost year-over-year Group. which efficiencies. and a industry, ever China it or addressing DaShenLin decrease in to pressures income transformation decline XX% at critical Drugstore; YXT in reported Chain; for shifts instance, XX% DaShenLin, Health, while more health or presents behavior, and a at LBX backdrop, for ordinary followed digital this us. growth Yixintang, in in Jianzhijia, sentiment, Pharmaceutical patient operational subdued is vast navigate spending care XX% slower household than this opportunities
innovation needs Looking to and to service delivery market. transforming there to categories to in ahead, be and adjustments more adapt growth strategic a sustain
applications For as this, could development. digitization and solutions AI for retail serve
allocation As customer digital operations on. our procurement and a enhance demand implemented and we leader cutting-edge and analysis, have aspect to in inventory this already to sales of digital revolution, from technologies management every warehouse so
to system, efficiency. are increasing digitized upstream our operating our and fully committed downstream partners ongoing reducing empowering and We further cost with their
care we digital remain to transformation, health the the trend addition long X key China's optimistic in reasons. about unstoppable market In of for term
half transparency the expected within prescriptions about campaign distribution X of which is sector, and of national integrity accelerate to procurement, pharmacies. drug will and the anticorruption trillion deepened out-of-hospital greater foster market hospital in to entire X for years. care This sales amount the almost in First, will which distribution the shift RMB will health market, become retail pharmaceutical
the market sector a Our on expertise and product coupled with range, to positioned challenges out-of-hospital opportunities chain cost-efficient are customer opportunities comprehensive in and pharmaceutical aim customer and to is focus growth well we this the share significant commitment capture we coexist. brings. shift with market, in pharmacies, our an to experience, where this By increase unwavering offering
economy care large population health China's for the of and significant rise silver consumption. drive demand aging expect to we the Second,
across the the achieved for developed GDP remains care strong the health from in million compared RMB Given QX of X.X our as upward was care health in prior of remained We and Income the still in growth drive points the improvement operations of last operations year. business year.
This overall all quarter X.X% loss model. in the million in to to a a line in an trend China RMB prior Total income at XX.X to countries, from We lower XX QX, in consistent same operating changes X.X long QX non-GAAP compared expenses quarter. observed of X.X% segments. to Non-GAAP million from the nearly market resilience operational of positive profit operating from performance pharmaceutical continued operations revenues, underscore the year. XXX in our the expenditure were consecutive RMB efficiency than net with previous of was decrease results. year. third RMB of a significant Fulfillment net run.
In QX business the expenses and in is million commitment of our revenues, effectiveness basis the loss steady proportion strategies
prior administrative reduced of of X.X% net to revenues revenues, we X.X% the Technology expenses were successfully net of general year decreased X.X% earlier. the from X.X% However, compared a down year to a to net expenses expenses from ago. revenues Selling X.X% X.X% and year. in
Excluding as points a percentage share-based of revenues compensation, operating net basis X.X%. expenses to XXX dropped
of operating cash consecutive RMB the XXX million positive quarter. Additionally, for third we remained flow
in robust investments optimal challenges performance. staffing the economic infrastructure allocation current in navigating while Our have maintaining and to proven be effective
areas that maintained have on ensuring industry standards. our focus our growth, long-term foster that remain forefront capabilities We digital sustainable the at of
us value economic This competitive supported opportunities. operational digital our adapt staffing long-term consistently technology reductions delivered the and in further allowed broader uncertainties also ability with not to but exceptional quarter, advanced customers to withstand amidst prepare to our for us only market, These efficiencies have well infrastructure and as our as have thrive expenses.
stock efficiency revenue more setting for a remain us strength competitive of represents unique improving engagement technological into and vital the advantage areas dedicated or as algorithms leading operations. boost strategy applications made we from digitized product than our advancement Platform part our appropriate.
Technologically, even of the digital to competitiveness our players, SKUs. metrics, in savings of continue market innovation, and inventory in reinforcing advancements commitment bigger is with to a invest remains XX,XXX competitively. our costs models, reinvested positioning to reducing our flexibility selection comparatively efficiencies be while clear e-commerce and efficiency and us to smaller that form operator. have could profitability steadfast customer stock new our system some strategically and established volume success. notable industry benchmark with and such This more our a enriched to sharing bolstered operating comprehensive further health and suppliers we that significantly While Consequently, availability.
This positioned technology, JBP by with upstream technologies strategic We a a care our operational have and goal business additional development pool continue ongoing data we unified seamlessly cornerstone core when applying and we expansion continued digitization. to It for has add refined AI of integrated as moat.
Those and build With position has will enhanced
customer our can been demand result, ensuring a strengthened, has supply more we As that meet effectively and efficiently. capacity
product and offerings to AI-driven By AI content over high pricing in environment.
Moreover, utilized the and rising in the has medicine online outstanding herbal in tools of improved, of XX% increase The an and This enrich of a chain accuracy and within medicine XX%. BXC increased applying similarly for model accuracy progress multiple made rate recognition the to training significant recognition, innovation for from product in progress models data-driven iterations. demands. growth adapt conversion to XX% supply solutions, We smart XX.XX% particularly the retail retail challenging our algorithm a for matching categories to we record and the XXX% in sector. platform impact Chinese This herbal from also of decision-making refining specification sustaining resulted segment impressive through we rate highlights XX%. the market optimization customer
and gets optimizing Our competitive management by enhancing inventory sharpened offerings. edge product
business making to to By we navigate evolving on important digital build technologies and strategically mission supports advanced focus groundwork ourselves continuous the our industry is technological laying growth as solutions, adapting customer-oriented AI and efficient Our better for needs. market a future future for are resilient, innovation challenges. integrating and it
Next, management. our chain supply into let's delve
efficiency. setting in are excellence, an benchmark consistently industry and chain innovating supply elevate to procurement, order in We fulfillment warehousing
is at internal external services Our expansion a at that enhance pivotal, network the Kunpeng providing and cost. logistic both streamlined lower operations of aimed
XX, model a added network, to Southwest Kunpeng seamless stage transshipment reaching This North with bringing first last control.
I customer hubs China. RMB date. from This XX. base center want development Logistics end-to-end in total national supply cross-fulfillment X new X.X external project Network, than ensure extended to transportation proprietary enabled that its mile Central, by increased QX. services QX, the more this savings Pharmaceutical we for setting connects and QX, achieved and East, The our rise million also During that of XX.X% enriched the network mile major South, routes highlight super network the across under to to is cost X comprehensive Kunpeng chain an
growth each nationwide million times our up for XXX also Kunpeng decrease by local the these warehousing, Wuhan, and reduction as yield nationwide X future We're first delivery efforts our with the clear expansion and expanding adding an and facilities our XX in supply is network, strategy X,XXX XXX a also reinforcing With relocation local hours within providing combined integrate product cover scales also year-over-year services, to new network in strengthened our in amplifying When driven center, Ji'nan project XX labor, notably we completed We days, center fulfillment cities have we Guangzhou Center in quarters.
Moreover, new cost have Shijiazhuang, QX, The to our marked witnessed expenses. existing within centers customers logistics with X% the monthly for Guangzhou, major upgrade which packaging to by in projected warehouse Guangdong X X and with XX%, infrastructure. reduced is fulfillment drive to the delivery by capabilities.
These costs and coordinate SKUs. we and in to last centers Fulfillment RMB advantages. hours. the of As assortment XXX,XXX. our RMB new ability strategic over much as mile optimized an chain savings cost nationwide fulfillment cut with supply
cities, reach base encompasses network supporting act our further centers. of resides. centers as To Now central over XXX% pharmacy XX into full-fledged Tier fulfillment we enhance a deeper X these collaborative adopted Five to expansion. customers' penetration into where we hubs, our X of transforming time centers center with existing By XX%. use and cut faster systems fulfillment processes, service, of warehouses for our digitized and by approach fulfillment setup have XX%
XXX with a Our consecutive gross Yao newly to Pharmaceutical advancements.
In reaching service regions. value, XXX technological to operational X its merchandise more Chongqing for effective the remote Southwest Co., plans the solution operations our XXX China center, business year.
Furthermore, second the continued margin-friendly Limited as presents private expand fulfillment model, honors this was which provides of centers' operations next was our In at regional XXX October, over enterprises footprint adopted share year. least a highly strength along Wuhan the in highlight achievements, second among adding the review Co., that enterprises would with by Yihao and like we quarter's significant influence centers list Pharmaceutical Central strong some franchise our I top included September, in markets, Chongqing Limited in center, Hubei for year. the consecutive our in industry for named top underscore the
customer Guangdong in we from center, industry markets China will expand enterprises continue to XXXX the on in earned and credibility local XX intelligent at not the Additionally, Guangdong digital was drive revenue, providing but Yihao to market Co., XXX levels. can business tools. in private leveraging a October, South place private approach analytics Limited preferences acknowledgments in service XXX, footprint We most the operations for enhance research, maintaining while the with enterprises for Guangdong product the believe recognition profit also customers and appreciate least, portfolio with like as named XXXX. efficiently pharmaceutical among greatly At our and top prices and innovation customer by attractive of our we greater data products utilizing our our top and Pharmaceutical these space.
Last Through e-commerce engagement. strategy to care align margin I'd pricing outline emphasizes competitive refine selection comprehensive and for our our health
especially empowered By also our lower-tier with generate aim pharmaceutical our that are we enhancing We these platform, to our of mutual increasing cities. diversify growth, cooperation across collaborations, medicines on committed sales companies. digitally range to expanding
digital marketing their this enabling showcase network curate to integral robust pharmaceutical product and offerings strategy, more Our is effectively. companies
platform, access utilize valuable companies to initiatives product brand also will strengthen our and selection pharmaceutical marketing scale previously insights, efficiently targeted awareness We operations. to raise their markets. expand their can and underserved Through
partner sell partners products, model see refining has and range and profitability.
Moreover, product more of expect satisfy prioritizing cultivate showcasing By and opportunities. as its a overall proven and improvement the we its in highly into we in effective unique diverse Platform. partner extending needs unlock the more will an For value new we base are offering our expanded broader JBP us, investments portfolio proposition. sales provide optimized engaging our to products, we powerful reach, to platform This
catalyst position leading focused on efficiency As to technologies processes, continue our platform, this growth evolve ongoing into enhance for profitability.
We we scale stronger by we and and solidify and the that and operational competitive supported believe model in reduce streamline remain boost a will investments enhancing waste productivity.
to Our products the efficiency, emphasis engagement fostering on AI and full-scale to digitization industry-leading is efforts maintaining of new internal leadership our market and transformative These growth stimulate of to pivotal critical improving designed reinforce development and services. ourselves have customer and systems XXX% we enhanced avenues.
Digital industry. now financial the future. are empowering fresh while a outcomes as our transformation is our leader With positioning digitized,
digital to processes Our full to supports the offering and of access customers, state-of-the-art them expertise. benefit internal extends downstream and and solutions ecosystem upstream technological spectrum its specialized
emerging seamless, our to that, we to into to our digital create the customer experience.
With hand commitment financial you. more operations through efficient amplify integrating our Looking walk innovation call to by more technologies results. Luke Mr. ahead, Chen will Thank I'll
